Oncology CRO | Charles River Discovery Research Services

Radiation 

Charles River Discovery Services is licensed to carry out biodistribution studies with C14- and H3-labeled molecules. Biodistribution studies with C- and H-labeled molecules help determine the targeting and tumor specificity of a test agent. On-site determination of radiolabeled levels in samples is possible.

We also have the capability of administering radiation as a therapy using a Faxitron Model CP-160 instrument. This capability enables the use of radiation for:

  • Combination radiation/chemotherapy
  • Myeloablation
  • In vitro applications


For more information about our radiation services, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jun 13 - Neurological Biomarkers in Efficac...
Jun 06 - GLP-Compliant ELISpot and FluoroSp...
Jun 24-Jun 26 - London, UK - Skin Forum 2013
Jun 21-Jun 25 - Chicago, IL - American Diabetes Association’s 73rd Scientific Sessions
Sep 09-Sep 11 - Carlsbad, CA - 19th Annual Biotechnology-Derived Therapeutics Perspecti...
Jun 28-Jun 28 - Frankfurt, Germany - Seminar: Health Monitoring of Laboratory Animals

Charles River Laboratories, Inc.